Literature DB >> 32002911

Intra-bone Bone Marrow Transplantation in Pig-to-Nonhuman Primates for the Induction of Tolerance Across Xenogeneic Barriers.

Kazuhiko Yamada1, Yuichi Ariyoshi2, Thomas Pomposelli2, Kazuhiro Takeuchi2.   

Abstract

Mixed chimerism and thymic tissue transplantation strategies have achieved xenogeneic tolerance in pig-to-mouse models, and both have been extended to pig-to-baboon models. A mixed chimerism strategy has shown promise toward inducing tolerance in allogeneic models in mice, pigs, nonhuman primates (NHP), humans, and a rat-to-mouse small animal xeno-model. However, even though α-1,3-galactosyltransferase gene knockout (GalTKO) pigs have been used as bone marrow (BM) donors, direct intravenous injection of porcine BM cells was detected for only up to 4 days (peripheral macro-chimerism) in one case, and the rest lost chimerism within 2 days.Recent data in allogeneic models demonstrated that direct injection of donor BM cells into recipient BM spaces (intra-bone bone marrow transplantation: IBBMTx) produces rapid reconstitution and a higher survival rate compared to i.v. injection. In order to minimize the loss of injected porcine BM peripherally before reaching the BM space, Yamada developed a xeno-specific regimen including IBBMTx coated with a collagen gel matrix in a preclinical pig-to-baboon model (Yamada IBBMTx). This strategy aims to achieve improved, persistent macro-chimerism as well as engraftment of BM across a xenogeneic barrier. The initial study published in 2015 demonstrated that this IBBMTx strategy leads to markedly prolonged peripheral macro-chimerism detectable for up to 23 days. Furthermore, a more recent study using human CD47-transgenic (Tg) GalTKO pigs as xeno-donors achieved long-lasting macro-chimerism >60 days with evidence of reduction of anti-pig natural antibodies (nAb). This is the longest macro-chimerism that has ever been achieved in a preclinical large animal xenotransplant model to date. In this chapter, we introduce a brief summary of our achievements in regard to successful tolerance induction by utilizing our novel strategy of IBBMTx as well as describe the step-by-step methodology of surgical and in vitro procedures that are required for this project.

Entities:  

Keywords:  Human CD47 transgenic; Intra-bone bone marrow transplantation; Pig-to-baboon model; Tolerance; Xenotransplantation

Year:  2020        PMID: 32002911      PMCID: PMC7412596          DOI: 10.1007/978-1-0716-0255-3_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  37 in total

1.  Occurrence of specific humoral non-responsiveness to swine antigens following administration of GalT-KO bone marrow to baboons.

Authors:  Adam Griesemer; Fan Liang; Atsushi Hirakata; Erica Hirsh; Diana Lo; Masayoshi Okumi; Megan Sykes; Kazuhiko Yamada; Christene A Huang; David H Sachs
Journal:  Xenotransplantation       Date:  2010 Jul-Aug       Impact factor: 3.907

2.  Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue.

Authors:  Kazuhiko Yamada; Koji Yazawa; Akira Shimizu; Takehiro Iwanaga; Yosuke Hisashi; Matthew Nuhn; Patricia O'Malley; Shuji Nobori; Parsia A Vagefi; Clive Patience; Jay Fishman; David K C Cooper; Robert J Hawley; Julia Greenstein; Henk-Jan Schuurman; Michel Awwad; Megan Sykes; David H Sachs
Journal:  Nat Med       Date:  2004-12-26       Impact factor: 53.440

3.  Humoral tolerance in xenogeneic BMT recipients conditioned by a nonmyeloablative regimen.

Authors:  I Aksentijevich; D H Sachs; M Sykes
Journal:  Transplantation       Date:  1992-05       Impact factor: 4.939

4.  Normal development in porcine thymus grafts and specific tolerance of human T cells to porcine donor MHC.

Authors:  B Nikolic; J P Gardner; D T Scadden; J S Arn; D H Sachs; M Sykes
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

5.  Skin graft tolerance across a discordant xenogeneic barrier.

Authors:  Y Zhao; K Swenson; J J Sergio; J S Arn; D H Sachs; M Sykes
Journal:  Nat Med       Date:  1996-11       Impact factor: 53.440

6.  Pig kidney graft survival in a baboon for 136 days: longest life-supporting organ graft survival to date.

Authors:  Hayato Iwase; Hong Liu; Martin Wijkstrom; Huidong Zhou; Jagjit Singh; Hidetaka Hara; Mohamed Ezzelarab; Cassandra Long; Edwin Klein; Robert Wagner; Carol Phelps; David Ayares; Ron Shapiro; Abhinav Humar; David K C Cooper
Journal:  Xenotransplantation       Date:  2015-06-29       Impact factor: 3.907

7.  Attenuation of phagocytosis of xenogeneic cells by manipulating CD47.

Authors:  Hui Wang; Jon VerHalen; Maria Lucia Madariaga; Shuanglin Xiang; Shumei Wang; Ping Lan; Per-Arne Oldenborg; Megan Sykes; Yong-Guang Yang
Journal:  Blood       Date:  2006-09-28       Impact factor: 22.113

8.  Upregulation of CD80 on glomerular podocytes plays an important role in development of proteinuria following pig-to-baboon xeno-renal transplantation - an experimental study.

Authors:  Christopher J Rivard; Tatsu Tanabe; Miguel A Lanaspa; Hironosuke Watanabe; Shunichiro Nomura; Ana Andres-Hernando; Krystle Garth; Mitsuhiro Sekijima; Takuji Ishimoto; Yuichi Ariyoshi; Gabriela E Garcia; Jigesh Shah; Boyd Lennan; Masayuki Tasaki; Thomas Pomposelli; Akira Shimizu; David H Sachs; Richard J Johnson; Kazuhiko Yamada
Journal:  Transpl Int       Date:  2018-06-05       Impact factor: 3.782

9.  Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates.

Authors:  Bernhard J Hering; Martin Wijkstrom; Melanie L Graham; Maria Hårdstedt; Tor C Aasheim; Tun Jie; Jeffrey D Ansite; Masahiko Nakano; Jane Cheng; Wei Li; Kathleen Moran; Uwe Christians; Colleen Finnegan; Charles D Mills; David E Sutherland; Pratima Bansal-Pakala; Michael P Murtaugh; Nicole Kirchhof; Henk-Jan Schuurman
Journal:  Nat Med       Date:  2006-02-19       Impact factor: 53.440

10.  Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism.

Authors:  Y G Yang; E deGoma; H Ohdan; J L Bracy; Y Xu; J Iacomini; A D Thall; M Sykes
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

View more
  2 in total

Review 1.  Cellular Immune Responses in Islet Xenograft Rejection.

Authors:  Min Hu; Wayne J Hawthorne; Shounan Yi; Philip J O'Connell
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

Review 2.  Progress towards xenogenic tolerance.

Authors:  Erin M Duggan; Adam Griesemer
Journal:  Curr Opin Organ Transplant       Date:  2020-10       Impact factor: 2.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.